Cano Health, Inc.

CANO

Valor de mercado US$ 6,64 mi

Accelerates Transformation Plan, Now Targeting $290 million of Cost Reductions MIAMI , Dec. 29, 2023 /PRNewswire/ -- Cano Health, Inc. (NYSE: CANO) (" Cano Health " or the " Company ") announced today that it was notified by NYSE Regulation Inc. (the " NYSE ") that it is not in compliance with Section 802.01B of the NYSE Listed Company Manual (the " Listing Rule ") because the Company's total market capitalization has been less than $50 million over a 30 trading-day period and its stockholders' equity is less than $50 million. Pursuant to the Listing Rule, the Company has 10 business days from receipt of the Notice to send a letter to the NYSE confirming receipt of the Notice and to indicate whether it intends to cure the deficiencies.

Patricia Ferrari and Carol Flaton to Enhance the Board's and Management's Ongoing Strategic, Operational and Financing Initiatives MIAMI , Dec. 18, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, today announced the appointment of Patricia Ferrari and Carol Flaton to its Board of Directors. Ms. Ferrari and Ms.

NEW YORK , Nov. 20, 2023 /PRNewswire/ -- (PRNEWSWIRE) Pomerantz LLP is investigating claims on behalf of investors of Cano Health, Inc. ("Cano" or the "Company") (NYSE: CANO). Such investors are advised to contact Robert S.

Cano Health Inc's cash flow challenges appear ‘daunting' as the primary care provider's recent quarterly losses swelled, according to UBS analysts.  In an update to clients, they downgraded Cano Health stock from ‘Neutral' to a ‘Sell', while slashing its price target to $3.75 per share from $12 previously, as the analysts believe elevated third-party medical expenses will have a sustained negative effect on the company's already challenged liquidity position.